Pitch deck

Atomwise's pitch deck

The deck, and the 6 rounds we watched Atomwise raise afterwards, with the investors each report named.

Atomwise is a technology-enabled pharmaceutical company that focuses on small-molecule drug discovery using deep learning. Its mission is to create better medicines faster by exploring a vast array of chemical compounds to find novel, drug-like molecules. The company developed AtomNet®, the first convolutional neural network specifically designed for drug discovery, which screens over 16 billion synthesizable molecules against biological targets in less than two days. Atomwise has made significant strides in unlocking challenging disease targets, tackling over 600 unique targets that traditional methods find difficult to address. The company has raised over $174 million in funding and has established a deal value approaching $7 billion through numerous collaborations. With 775 partnerships worldwide, including a strategic collaboration with Sanofi, Atomwise serves organizations in the pharmaceutical, agrochemical, and biotechnology sectors, focusing on innovative solutions for complex biological mechanisms.

Read the deckFree account. The deck belongs to Atomwise, so reading it needs one; everything on this page is public.